BAT1706 clinical trials
Also written BAT1706.
A product of Bevacizumab; its studies count on that page too.
How each study uses BAT1706 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 26 Feb 2004 · AVASTIN · BLA 125085 (FDA, Drugs@FDA; as Bevacizumab)
- European Union
- 12 Jan 2005 · Avastin · EMEA/H/C/000582 (EMA; as Bevacizumab)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A biosimilar of Bevacizumab
Studies
Open first, then newest update. How each study uses BAT1706 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 InjectionCompletedPhase 1Bio-Thera SolutionsNCT05865574Written as BAT1706 Injection
- A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCCCompletedPhase 2BeiGeneNCT04948697Written as BAT1706
- A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung CancerCompletedPhase 3Bio-Thera SolutionsNCT03329911Written as BAT1706
- Study of Bevacizumab(BAT1706) and Comparators in Healthy SubjectsCompletedPhase 1Bio-Thera SolutionsNCT03030430Written as BAT1706 injection